e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Allergen immunotherapy and anti-immunoglobulin E
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ROMA (registry omalizumab in Malaga): Study of 84 patients
M. Martin-Rebollo, A. Padilla Galo, M. P. Alfonso, L. N. Alberto (Malaga, Marbella, Spain)
Source:
Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Session:
Allergen immunotherapy and anti-immunoglobulin E
Session type:
Poster Discussion
Number:
274
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Martin-Rebollo, A. Padilla Galo, M. P. Alfonso, L. N. Alberto (Malaga, Marbella, Spain). ROMA (registry omalizumab in Malaga): Study of 84 patients. Eur Respir J 2011; 38: Suppl. 55, 274
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Experience of patients treated with nintedanib in the Community of Madrid. REFIPIMAD Registry
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Protocol for the EARCO Registry: a pan-European observational study in patients with a
1
-antitrypsin deficiency
Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019
Year: 2020
Longitudinal data-driven definition of clinical asthma phenotypes in the pediatric arm of the All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL)
Source: Virtual Congress 2020 – Hot topics in paediatric asthma
Year: 2020
An assessment of the use of palivizumab over 12 years from a Canadian Registry (CARESS).
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
ECME: Epidemiologic study of the characteristics of women with COPD in Spain
Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Year: 2011
Development of the Birmingham Lung Improvement Studies (BLISS) prognostic score for COPD patients in primary care: data from the Birmingham COPD cohort
Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care
Year: 2019
Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020
Unbiased clinical cluster analysis of patients of ProAR Asthma Cohort.
Source: International Congress 2018 – New modalities in asthma treatment
Year: 2018
Work-related COPD risk in the population-based UK Biobank cohort study
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015
(in)Appropriate LAMA Prescribing in Asthma patients: a Cohort Analysis (the ALPACA study)
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Interim results of the Greatest International ANti-infective Trial (GIANT) in patients with AECB
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019
Systemic antibiotherapy in patients admitted with an acute exacerbation of COPD. Association with mortality and readmissions. Experience from the pilot study in six regions of the Nacional Clinical Audit on COPD exacerbation in Spain (AUDIPOC)
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010
A cross-sectional survey of Maltese patients’ preferences for receiving a cancer diagnosis
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Survival among never and ever smokers with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) study
Source: Annual Congress 2010 - Epidemiology of lung cancer
Year: 2010
LATE-BREAKING ABSTRACT: Association between sleep apnoea and cancer mortality. Longitudinal muticenter study in 5,467 patients from the Spanish cohort
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
A cohort evaluation of WHO class II and IV TB patients treated at the National Institute of Respiratory Diseases (INER)
Source: Eur Respir J 2001; 18: Suppl. 33, 474s
Year: 2001
Prevalence of co-morbidities in a Hellenic COPD population (COMPACT study)
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept